Search
Menu
Rocky Mountain Instruments - Custom Assemblies LB

MediSpectra Begins Luma Trial

Facebook X LinkedIn Email
LEXINGTON, Mass., Oct. 11 -- Medical device company MediSpectra Inc. said it has begun enrolling patients in a major clinical study of its cervical imaging system, Luma, at thirteen sites in the US. The study of 2200 women with abnormal Pap smears will compare the performance of Luma as an adjunct to colposcopy (the current method for evaluating Pap smear results) to colposcopy alone. In a 12-second optical scan, Luma collects biochemical and cellular characteristics from a patient's cervical tissue. Areas of the cervix with high-grade precancerous lesions are then identified and displayed on...Read full article

Related content from Photonics Media

    Published: October 2002
    News & Features

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.